What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News AnaptysBio shares soar 37% after rheumatoid arthritis candidate rosnilimab delivers promising Phase 2b trial results AnaptysBio, Inc. experienced a significant boost in its market performance as shares surged 37% in premarket trading following… byPallavi MadhirajuFebruary 12, 2025